+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Netupitant & Palonosetron Hydrochloride Capsules Market - Global Forecast 2025-2030- Product Image
Netupitant & Palonosetron Hydrochloride Capsules Market - Global Forecast 2025-2030- Product Image
Sale

Netupitant & Palonosetron Hydrochloride Capsules Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6138639
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The market for netupitant plus palonosetron capsules is experiencing pivotal changes as healthcare systems worldwide move toward more coordinated, patient-focused antiemetic strategies. Senior stakeholders face new strategic and operational considerations as combination therapies transform both clinical and commercial landscapes.

Market Snapshot: Netupitant plus Palonosetron Capsules

The antiemetic therapy market is witnessing a dynamic transition, underscored by the integration of dual-mechanism solutions like netupitant and palonosetron into oncology and surgical care pathways. Key drivers include evolving regulatory requirements, a sharpened focus on value-based outcomes, and the increasing importance of payer alignment. Regulatory developments and innovations in digital health are recalibrating competitive positioning and accelerating strategic collaborations across industry segments.

Scope & Segmentation: Comprehensive Market Coverage

  • Indication: Segmented into chemotherapy-induced nausea and vomiting (with acute, anticipatory, breakthrough, delayed phases), postoperative nausea and vomiting (general and orthopedic surgery), and radiation-induced nausea and vomiting (brachytherapy and external beam therapy).
  • Distribution Channels: Analysis covers hospital pharmacies (inpatient and outpatient), online pharmacies (on-demand and subscription services), and retail pharmacies (chain and independent models).
  • End Users: Includes home care patients (nurse- and self-administered regimens), hospitals (private and public), and oncology centers (hospital-attached and standalone).
  • Route of Administration: Compares intravenous and oral delivery modalities, impacting clinical protocols and user preferences.
  • Dosage Strength: Addresses the standardized combination of netupitant 300 mg and palonosetron 0.5 mg.
  • Regional Coverage: In-depth assessment of Americas (including the United States and major state-level markets), Europe/Middle East/Africa (key economies such as Germany, United Kingdom, France, and emerging regions), and Asia-Pacific (China, India, Japan, Australia, and high-growth Southeast Asian markets).
  • Company Analysis: Review of major industry players including Helsinn Healthcare SA, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, Dr. Reddy’s Laboratories Ltd, Apotex Inc, Aurobindo Pharma Limited, Viatris Inc, Accord Healthcare Limited, and Zydus Lifesciences Limited.

Key Takeaways for Senior Decision-Makers

  • The adoption of combination antiemetic therapies is reshaping treatment protocols, enabling more nuanced management across both acute and delayed response phases.
  • Distinct distribution models, from hospital and retail pharmacies to direct-to-home solutions, require tailored engagement and logistical strategies to ensure product accessibility and adherence support.
  • The move toward outcome-focused and patient-centered care is amplifying the value of digital monitoring tools, adherence programs, and cross-industry partnerships within the antiemetic segment.
  • Regional disparities in regulatory timelines, local manufacturing, and reimbursement structures are influencing market entry and expansion strategies for both established and emerging markets.
  • Strategic alliances between pharmaceutical developers and technology providers offer pathways for real-world data capture, educational outreach, and supply chain optimization.
  • Segment-focused insights empower leaders to refine commercial and clinical approaches, helping organizations differentiate offerings amid rising competition and evolving payer requirements.

Tariff Impact and Supply Chain Adaptation

Recent United States tariff modifications on pharmaceutical imports have made supply chains for netupitant plus palonosetron capsules more complex. Increased import duties on combination products are prompting manufacturers and distributors to reassess procurement, negotiate logistics agreements, and consider diversification of manufacturing locations. Inventory strategies now balance margin protection with capital efficiency, while regional warehousing and nearshoring are under review to offset tariff-related costs.

Methodology & Data Sources

This market analysis integrates primary interviews with oncologists, pharmacists, and supply chain leaders, supplemented by targeted secondary research from regulatory sources, clinical trial records, and peer-reviewed studies. The research employs data triangulation to validate insights, supported by regional scenario planning and industry workshops for in-depth trend verification.

Why This Report Matters

  • Empowers decision-makers to benchmark market positions and optimize entry or expansion strategies based on granular, segmentation-driven intelligence.
  • Delivers actionable insight into regional market shifts, regulatory developments, and the strategic importance of supply chain adjustments impacted by tariffs.
  • Facilitates alignment of commercial, operational, and clinical teams by presenting validated, investor-grade analytics to inform product lifecycle management.

Conclusion

Combination antiemetic therapies represent a significant advance in clinical care and market practice. This report enables senior leaders to anticipate evolving trends, manage operational risk, and support successful product deployment in a changing global landscape.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Evolving reimbursement policies impacting netupitant and palonosetron market access in oncology
5.2. Expansion of real-world evidence demonstrating improved delayed-phase CINV control with netupitant and palonosetron combinations
5.3. Strategic partnerships between leading biopharma companies to broaden netupitant and palonosetron therapy distribution networks
5.4. Development and market introduction of cost-effective generics and biosimilars challenging branded netupitant and palonosetron pricing dynamics
5.5. Incorporation of digital health platforms for remote monitoring of patient adherence and treatment outcomes in CINV management with netupitant and palonosetron
5.6. Recent regulatory approvals and label expansions of netupitant and palonosetron capsules for pediatric and geriatric oncology indications
5.7. Rapid growth in emerging Asia Pacific markets driving increased volume sales and localized production of netupitant and palonosetron capsules
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Netupitant & Palonosetron Hydrochloride Capsules Market, by Indication
8.1. Introduction
8.2. Chemotherapy Induced Nausea And Vomiting
8.2.1. Acute Phase
8.2.2. Anticipatory Phase
8.2.3. Breakthrough Phase
8.2.4. Delayed Phase
8.3. Postoperative Nausea And Vomiting
8.3.1. General Surgery
8.3.2. Orthopedic Surgery
8.4. Radiation Induced Nausea And Vomiting
8.4.1. Brachytherapy
8.4.2. External Beam Therapy
9. Netupitant & Palonosetron Hydrochloride Capsules Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.2.1. Inpatient Pharmacy
9.2.2. Outpatient Pharmacy
9.3. Online Pharmacy
9.3.1. OnDemand Service
9.3.2. Subscription Service
9.4. Retail Pharmacy
9.4.1. Chain Pharmacy
9.4.2. Independent Pharmacy
10. Netupitant & Palonosetron Hydrochloride Capsules Market, by End User
10.1. Introduction
10.2. Home Care
10.2.1. NurseAdministered
10.2.2. SelfAdministered
10.3. Hospital
10.3.1. Private Hospital
10.3.2. Public Hospital
10.4. Oncology Center
10.4.1. HospitalAttached Center
10.4.2. Standalone Center
11. Netupitant & Palonosetron Hydrochloride Capsules Market, by Route Of Administration
11.1. Introduction
11.2. Intravenous
11.3. Oral
12. Netupitant & Palonosetron Hydrochloride Capsules Market, by Dosage Strength
12.1. Introduction
12.2. Netupitant 300 Mg Palonosetron 0.5 Mg
13. Americas Netupitant & Palonosetron Hydrochloride Capsules Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Netupitant & Palonosetron Hydrochloride Capsules Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Netupitant & Palonosetron Hydrochloride Capsules Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Helsinn Healthcare SA
16.3.2. GlaxoSmithKline plc
16.3.3. Teva Pharmaceutical Industries Ltd
16.3.4. Sandoz International GmbH
16.3.5. Dr. Reddy’s Laboratories Ltd
16.3.6. Apotex Inc
16.3.7. Aurobindo Pharma Limited
16.3.8. Viatris Inc
16.3.9. Accord Healthcare Limited
16.3.10. Zydus Lifesciences Limited
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET: RESEARCHAI
FIGURE 26. NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET: RESEARCHSTATISTICS
FIGURE 27. NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET: RESEARCHCONTACTS
FIGURE 28. NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA AND VOMITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA AND VOMITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ACUTE PHASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ACUTE PHASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ANTICIPATORY PHASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ANTICIPATORY PHASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY BREAKTHROUGH PHASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY BREAKTHROUGH PHASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DELAYED PHASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DELAYED PHASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA AND VOMITING, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA AND VOMITING, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RADIATION INDUCED NAUSEA AND VOMITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RADIATION INDUCED NAUSEA AND VOMITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY EXTERNAL BEAM THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY EXTERNAL BEAM THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RADIATION INDUCED NAUSEA AND VOMITING, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RADIATION INDUCED NAUSEA AND VOMITING, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY INPATIENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY INPATIENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY OUTPATIENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY OUTPATIENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONDEMAND SERVICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONDEMAND SERVICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY SUBSCRIPTION SERVICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY SUBSCRIPTION SERVICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY NURSEADMINISTERED, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY NURSEADMINISTERED, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY SELFADMINISTERED, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY SELFADMINISTERED, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONCOLOGY CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONCOLOGY CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITALATTACHED CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITALATTACHED CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY STANDALONE CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY STANDALONE CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONCOLOGY CENTER, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONCOLOGY CENTER, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY NETUPITANT 300 MG PALONOSETRON 0.5 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY NETUPITANT 300 MG PALONOSETRON 0.5 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA AND VOMITING, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA AND VOMITING, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RADIATION INDUCED NAUSEA AND VOMITING, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RADIATION INDUCED NAUSEA AND VOMITING, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONCOLOGY CENTER, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONCOLOGY CENTER, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA AND VOMITING, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA AND VOMITING, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RADIATION INDUCED NAUSEA AND VOMITING, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RADIATION INDUCED NAUSEA AND VOMITING, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONCOLOGY CENTER, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONCOLOGY CENTER, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 161. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 162. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 163. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA AND VOMITING, 2018-2024 (USD MILLION)
TABLE 164. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA AND VOMITING, 2025-2030 (USD MILLION)
TABLE 165. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, 2018-2024 (USD MILLION)
TABLE 166. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, 2025-2030 (USD MILLION)
TABLE 167. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RADIATION INDUCED NAUSEA AND VOMITING, 2018-2024 (USD MILLION)
TABLE 168. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RADIATION INDUCED NAUSEA AND VOMITING, 2025-2030 (USD MILLION)
TABLE 169. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 172. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 173. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 174. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 175. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 176. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 177. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 180. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 181. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 182. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 183. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONCOLOGY CENTER, 2018-2024 (USD MILLION)
TABLE 184. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONCOLOGY CENTER, 2025-2030 (USD MILLION)
TABLE 185. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 186. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 187. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 188. CANADA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 189. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 190. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 191. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA AND VOMITING, 2018-2024 (USD MILLION)
TABLE 192. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA AND VOMITING, 2025-2030 (USD MILLION)
TABLE 193. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, 2018-2024 (USD MILLION)
TABLE 194. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, 2025-2030 (USD MILLION)
TABLE 195. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RADIATION INDUCED NAUSEA AND VOMITING, 2018-2024 (USD MILLION)
TABLE 196. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RADIATION INDUCED NAUSEA AND VOMITING, 2025-2030 (USD MILLION)
TABLE 197. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 200. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 201. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 202. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 203. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 204. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 205. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 208. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 209. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 210. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 211. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONCOLOGY CENTER, 2018-2024 (USD MILLION)
TABLE 212. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONCOLOGY CENTER, 2025-2030 (USD MILLION)
TABLE 213. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 214. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 215. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 216. MEXICO NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA AND VOMITING, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA AND VOMITING, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RADIATION INDUCED NAUSEA AND VOMITING, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RADIATION INDUCED NAUSEA AND VOMITING, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONCOLOGY CENTER, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ONCOLOGY CENTER, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA AND VOMITING, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA AND VOMITING, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA NETUPITANT & PALONOSETRON HYDROCHLORIDE CAPSULES MARKET SIZE, BY RADIATION INDUCED NAUSEA AND VOMITING, 2018-2024 (USD MILLION)
TABLE 25

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Netupitant & Palonosetron Hydrochloride Capsules Market report include:
  • Helsinn Healthcare SA
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd
  • Sandoz International GmbH
  • Dr. Reddy’s Laboratories Ltd
  • Apotex Inc
  • Aurobindo Pharma Limited
  • Viatris Inc
  • Accord Healthcare Limited
  • Zydus Lifesciences Limited

Related Topics

Related Reports

Netupitant-Palonosetron Fdc Market by Type, by Distribution Channel, and by Region - Product Image

Netupitant-Palonosetron Fdc Market by Type, by Distribution Channel, and by Region

  • Report
  • 200 Pages
  • Global
From
Netupitant-Palonosetron FDC Global Market Report 2025 - Product Image

Netupitant-Palonosetron FDC Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Palonosetron HCl API Market - Global Forecast 2025-2030 - Product Image

Palonosetron HCl API Market - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Palonosetron (CAS 135729-60-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Palonosetron (CAS 135729-60-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Post-Operative Nausea and Vomiting Market Report 2025 - Product Image

Post-Operative Nausea and Vomiting Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.